Objective: To evaluate the rate of eradication and bacterial resistance to treatment for Helicobacter pylori infection in patients at the Apoyo-Pichanaki Hospital in the year 2018. Material and methods: It corresponds to a descriptive, retrospective and cross-sectional study, using a sample of 327 clinical histories of patients with Helicobacter pylori infection, from January to December 2018, using the document analysis technique and the instrument the data record. Results: The eradication rate for Helicobacter pylori infection in patients of the Apoyo- Pichanaki Hospital was 91.4%, with optimal first-line therapeutic regimen with clarithromycin 500 mg, amoxicillin 1g and omeprazole 20 mg every 12 hours for 14 days, the highest rate being eradication in females with 60.9% and only 39.1% in males. The highest bacterial resistance was 25% for ages 44 to 48 years and for females, 8.6% of b...

La infección por Helicobacter pylori es un hallazgo frecuente en la población general, siendo su prevalencia mayor en personas que padecen patologías gastrointestinales, principalmente úlcera péptica (UP) y gastritis crónica. El objetivo de la presente investigación es evaluar la tasa de erradicación y resistencia bacteriana al tratamiento para infección por Helicobacter pylori en pacientes del Hospital Apoyo-Pichanaki, en el 2018. Por lo tanto, se aplicó el método científico, cuyo tipo de investigación es básico y el nivel de investigación es descriptivo. La muestra fue 327 Historias clínicas de pacientes con infección por Helicobacter pylori. Eencontrándose una tasa de erradicación para Helicobacter pylori del 91,4%, y un 8,6% de resistencia bacteriana a la primera y segunda línea de tratamientos utilizados.

Objective: To evaluate the rate of eradication and bacterial resistance to treatment for Helicobacter pylori infection in patients at the Apoyo-Pichanaki Hospital in the year 2018. Material and methods: It corresponds to a descriptive, retrospective and cross-sectional study, using a sample of 327 clinical histories of patients with Helicobacter pylori infection, from January to December 2018, using the document analysis technique and the instrument the data record. Results: The eradication rate for Helicobacter pylori infection in patients of the Apoyo- Pichanaki Hospital was 91.4%, with optimal first-line therapeutic regimen with clarithromycin 500 mg, amoxicillin 1g and omeprazole 20 mg every 12 hours for 14 days, the highest rate being eradication in females with 60.9% and only 39.1% in males. The highest bacterial resistance was 25% for ages 44 to 48 years and for females, 8.6% of b...